Proxy Votes Now

Home › Funds › Brighthouse › AVIP BlackRock Advantage Small Cap Growth Portfolio

AVIP BlackRock Advantage Small Cap Growth Portfolio proxy voting record 2025-2026

Fund family: Brighthouse · Filed by AUGUSTAR VARIABLE INSURANCE PRODUCTS FUND INC (CIK 315754) · SEC series S000007882

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,869 with, 2 against, 2,646 abstentions (not counted as with management); 9 items carried no recommendation; 19 split votes are in neither count. Shareholder proposals: 0 FOR, 0 AGAINST, 17 abstained, by the filing’s own vote-source field.

Compared with Brighthouse as a whole

The same two figures as Brighthouse’s manager page (247,741 ballot items across 83 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsBrighthouseItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)2.1%4,37776.3%204,500
Backed environmental and social shareholder proposals at US companiesn/a012.8%1,182

Where this fund voted differently from most Brighthouse funds

Each ballot item this fund voted is set against the votes of the other Brighthouse funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Brighthouse funds on 1,459 items (83.8% of the 1,741 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Brighthouse fundsMgmtResult
Atmus Filtration Technologies Inc.2026-05-12Advisory vote to approve the compensation of our named executive officers as disclosed in the proxy statement.AbstainFOR — 8 of 8 Brighthouse fundsAgainstPassed (calculated), 98.2% support
Atmus Filtration Technologies Inc.2026-05-12Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026.AbstainFOR — 8 of 8 Brighthouse fundsAgainstApproved, 100.0% support
Atmus Filtration Technologies Inc.2026-05-12Election of Directors: Diego DonosoAbstainFOR — 7 of 7 Brighthouse fundsAgainstElected, 98.0% support
Atmus Filtration Technologies Inc.2026-05-12Election of Directors: Heath SharpAbstainFOR — 7 of 7 Brighthouse fundsAgainstElected, 99.1% support
Atmus Filtration Technologies Inc.2026-05-12Election of Directors: Stephanie J. DisherAbstainFOR — 7 of 7 Brighthouse fundsAgainstElected, 99.3% support
Atmus Filtration Technologies Inc.2026-05-12Election of Directors: Stuart A. Taylor IIAbstainFOR — 7 of 7 Brighthouse fundsAgainstElected, 98.3% support
Rambus Inc.2026-04-23Election of Directors: Luc SeraphinAbstainFOR — 10 of 11 Brighthouse fundsAgainstPassed (calculated), 98.5% support
Rambus Inc.2026-04-23Ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 10 of 11 Brighthouse fundsAgainstPassed (calculated), 99.9% support
IonQ, Inc.2026-06-16To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026.AbstainFOR — 6 of 6 Brighthouse fundsAgainstApproved, 99.3% support
Spyre Therapeutics, Inc.2026-05-27To approve the Company's amended and restated 2016 Employee Stock Purchase Plan.AgainstFOR — 6 of 6 Brighthouse fundsAgainst—
Spyre Therapeutics, Inc.2026-05-27To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.AbstainFOR — 6 of 6 Brighthouse fundsAgainstApproved, 92.9% support
Spyre Therapeutics, Inc.2026-05-27To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AbstainFOR — 6 of 6 Brighthouse fundsAgainstApproved, 100.0% support
Scholar Rock Holding Corporation2026-06-04To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 6 of 6 Brighthouse fundsAgainstApproved, 99.3% support
SiteOne Landscape Supply, Inc.2026-05-13Advisory vote to approve Executive Compensation.AbstainFOR — 6 of 6 Brighthouse fundsAgainstApproved, 97.9% support
SiteOne Landscape Supply, Inc.2026-05-13Ratification of the selection of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending January 3, 2027.AbstainFOR — 6 of 6 Brighthouse fundsAgainstApproved, 99.7% support
Workiva Inc.2026-05-28Approval, on an advisory basis, of the compensation of Workiva's named executive officers.AbstainFOR — 6 of 6 Brighthouse fundsAgainstApproved, 69.8% support
Workiva Inc.2026-05-28Election of Directors: Julie IskowWithholdFOR — 6 of 6 Brighthouse fundsAgainstPassed (calculated), 72.4% support
Workiva Inc.2026-05-28Election of Directors: R. Scott HerrenWithholdFOR — 6 of 6 Brighthouse fundsAgainstPassed (calculated), 99.6% support
Garrett Motion Inc.2026-05-28The ratification of the appointment of Deloitte SA as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 6 of 6 Brighthouse fundsAgainstPassed (calculated), 99.3% support
Vistance Networks, Inc.2026-05-07Non-binding, advisory vote to approve the compensation of our named executive officers as described in the proxy statement.AbstainFOR — 6 of 6 Brighthouse fundsAgainstPassed (calculated), 99.1% support
Vistance Networks, Inc.2026-05-07Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026.AbstainFOR — 6 of 6 Brighthouse fundsAgainstPassed (calculated), 99.0% support
Coeur Mining, Inc.2026-05-12Advisory resolution to approve named executive officer compensation.AbstainFOR — 5 of 5 Brighthouse fundsAgainstApproved, 98.2% support
Coeur Mining, Inc.2026-05-12Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for 2026.AbstainFOR — 5 of 5 Brighthouse fundsAgainstApproved, 99.7% support
Life Time Group Holdings, Inc.2026-04-22To approve, by a non-binding vote, the named executive officer compensation as disclosed in the proxy statement.AbstainFOR — 5 of 5 Brighthouse fundsAgainstApproved, 95.3% support
Life Time Group Holdings, Inc.2026-04-22To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm.AbstainFOR — 5 of 5 Brighthouse fundsAgainstApproved, 98.7% support
Show the next 475
Items 26 to 500.
CompanyMeetingItemThis fundMost Brighthouse fundsMgmtResult
Praxis Precision Medicines, Inc.2026-06-10To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 5 of 5 Brighthouse fundsAgainstApproved, 99.9% support
Axsome Therapeutics, Inc.2026-06-05To approve, by non-binding advisory vote, the compensation of our named executive officers.AbstainFOR — 5 of 5 Brighthouse fundsAgainstApproved, 98.0% support
Axsome Therapeutics, Inc.2026-06-05To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AbstainFOR — 5 of 5 Brighthouse fundsAgainstApproved, 100.0% support
Mirum Pharmaceuticals, Inc.2026-06-15To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.AbstainFOR — 5 of 5 Brighthouse fundsAgainstApproved, 96.0% support
Mirum Pharmaceuticals, Inc.2026-06-15To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.AbstainFOR — 5 of 5 Brighthouse fundsAgainstApproved, 100.0% support
Travere Therapeutics Inc.2026-05-19To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares.AbstainFOR — 5 of 5 Brighthouse fundsAgainstApproved, 96.3% support
Travere Therapeutics Inc.2026-05-19To approve, on an advisory basis, the compensation of the Company's named executive officers.AbstainFOR — 5 of 5 Brighthouse fundsAgainstApproved, 97.3% support
Travere Therapeutics Inc.2026-05-19To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026.AbstainFOR — 5 of 5 Brighthouse fundsAgainstApproved, 99.9% support
Garrett Motion Inc.2026-05-28The election to the Company's board of directors of the eight nominees named in the Proxy Statement: D'aun NormanAbstainFOR — 5 of 5 Brighthouse fundsAgainstPassed (calculated), 98.3% support
Garrett Motion Inc.2026-05-28The election to the Company's board of directors of the eight nominees named in the Proxy Statement: Daniel NinivaggiAbstainFOR — 5 of 5 Brighthouse fundsAgainstPassed (calculated), 97.9% support
Garrett Motion Inc.2026-05-28The election to the Company's board of directors of the eight nominees named in the Proxy Statement: Joachim DreesAbstainFOR — 5 of 5 Brighthouse fundsAgainstPassed (calculated), 99.5% support
Garrett Motion Inc.2026-05-28The election to the Company's board of directors of the eight nominees named in the Proxy Statement: Julia SteynAbstainFOR — 5 of 5 Brighthouse fundsAgainstPassed (calculated), 99.6% support
Garrett Motion Inc.2026-05-28The election to the Company's board of directors of the eight nominees named in the Proxy Statement: Olivier RabillerAbstainFOR — 5 of 5 Brighthouse fundsAgainstPassed (calculated), 99.5% support
Garrett Motion Inc.2026-05-28The election to the Company's board of directors of the eight nominees named in the Proxy Statement: Steven TesoriereAbstainFOR — 5 of 5 Brighthouse fundsAgainstPassed (calculated), 99.5% support
Ambarella, Inc.2026-06-26To approve on a non-binding, advisory basis, the compensation of our named executive officers.AbstainFOR — 5 of 5 Brighthouse fundsAgainst—
Ambarella, Inc.2026-06-26To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending January 31, 2027.AbstainFOR — 5 of 5 Brighthouse fundsAgainst—
Blue Bird Corporation2026-03-11To ratify the appointment of the Company's independent registered public accounting firm for the 2026 fiscal year.AbstainFOR — 5 of 5 Brighthouse fundsAgainstApproved, 99.4% support
Ivanhoe Electric Inc.2026-06-04Ratification of the appointment of Deloitte LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 5 of 5 Brighthouse fundsAgainstPassed (calculated), 100.0% support
Ivanhoe Electric Inc.2026-06-04To seek a non-binding, advisory vote on the approval of our executive compensation.AbstainFOR — 5 of 5 Brighthouse fundsAgainstPassed (calculated), 98.6% support
Mativ Holdings, Inc.2026-04-30Non-Binding Advisory Vote to Approve Executive Compensation.AbstainFOR — 5 of 5 Brighthouse fundsAgainstPassed (calculated), 97.3% support
Mativ Holdings, Inc.2026-04-30Ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026.AbstainFOR — 5 of 5 Brighthouse fundsAgainstPassed (calculated), 99.4% support
HealthEquity, Inc.2026-06-25Approval of the HealthEquity, Inc. 2026 Employee Stock Purchase Plan.AgainstFOR — 8 of 9 Brighthouse fundsAgainstPassed (calculated), 99.7% support
HealthEquity, Inc.2026-06-25Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Adrian DillonAbstainFOR — 8 of 9 Brighthouse fundsAgainstPassed (calculated), 98.6% support
HealthEquity, Inc.2026-06-25Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Debra McCowanAbstainFOR — 8 of 9 Brighthouse fundsAgainstPassed (calculated), 98.4% support
HealthEquity, Inc.2026-06-25Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Evelyn DilsaverAbstainFOR — 8 of 9 Brighthouse fundsAgainstPassed (calculated), 98.5% support
HealthEquity, Inc.2026-06-25Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Gayle WellbornAbstainFOR — 8 of 9 Brighthouse fundsAgainstPassed (calculated), 98.9% support
HealthEquity, Inc.2026-06-25Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Rajesh NatarajanAbstainFOR — 8 of 9 Brighthouse fundsAgainstPassed (calculated), 99.8% support
HealthEquity, Inc.2026-06-25Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Robert SelanderAbstainFOR — 8 of 9 Brighthouse fundsAgainstPassed (calculated), 98.1% support
HealthEquity, Inc.2026-06-25Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Scott CutlerAbstainFOR — 8 of 9 Brighthouse fundsAgainstPassed (calculated), 99.5% support
HealthEquity, Inc.2026-06-25Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Stephen Neeleman, M.D.AbstainFOR — 8 of 9 Brighthouse fundsAgainstPassed (calculated), 98.9% support
HealthEquity, Inc.2026-06-25Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Stuart ParkerAbstainFOR — 8 of 9 Brighthouse fundsAgainstPassed (calculated), 99.7% support
HealthEquity, Inc.2026-06-25Election of ten directors to hold office until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified: William GassenAbstainFOR — 8 of 9 Brighthouse fundsAgainstPassed (calculated), 99.7% support
HealthEquity, Inc.2026-06-25To approve the Amended and Restated HealthEquity, Inc. 2024 Equity Incentive Plan.AbstainFOR — 8 of 9 Brighthouse fundsAgainstPassed (calculated), 96.9% support
HealthEquity, Inc.2026-06-25To approve, on a non-binding, advisory basis, the fiscal 2026 compensation paid to our named executive officers.AbstainFOR — 8 of 9 Brighthouse fundsAgainstPassed (calculated), 97.6% support
HealthEquity, Inc.2026-06-25To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending January 31, 2027.AbstainFOR — 8 of 9 Brighthouse fundsAgainstPassed (calculated), 99.4% support
ESCO Technologies Inc.2026-01-30To approve, on an advisory basis, the compensation of the Company's executive officersAbstainFOR — 8 of 9 Brighthouse fundsAgainstApproved, 98.4% support
ESCO Technologies Inc.2026-01-30To ratify the appointment of the Company's independent registered public accounting firm for the 2026 fiscal yearAbstainFOR — 8 of 9 Brighthouse fundsAgainstApproved, 99.9% support
Radnet, Inc.2026-06-02An advisory vote to approve the compensation of the Company's Named Executive Officers.AbstainFOR — 8 of 9 Brighthouse fundsAgainstApproved, 94.0% support
Radnet, Inc.2026-06-02The approval of an amendment and restatement to the Company's Equity Incentive Plan.AbstainFOR — 8 of 9 Brighthouse fundsAgainstApproved, 97.2% support
Radnet, Inc.2026-06-02The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AbstainFOR — 8 of 9 Brighthouse fundsAgainstApproved, 99.5% support
Modine Manufacturing Company2025-08-21Advisory approval of the Company's named executive officer compensation.AbstainFOR — 8 of 9 Brighthouse fundsAgainstApproved, 96.7% support
Modine Manufacturing Company2025-08-21Election of Directors: Mr. Mark BendzaAbstainFOR — 8 of 9 Brighthouse fundsAgainstPassed (calculated), 99.0% support
Modine Manufacturing Company2025-08-21Election of Directors: Mr. Neil D. BrinkerAbstainFOR — 8 of 9 Brighthouse fundsAgainstPassed (calculated), 98.3% support
Modine Manufacturing Company2025-08-21Ratification of the appointment of the Company's independent registered public accounting firm.AbstainFOR — 8 of 9 Brighthouse fundsAgainstApproved, 99.7% support
Ensign Group, Inc.2026-05-13Approval, on an advisory basis, of our named executive officers compensation.AbstainFOR — 7 of 8 Brighthouse fundsAgainstApproved, 94.6% support
Ensign Group, Inc.2026-05-13Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for 2026.AbstainFOR — 7 of 8 Brighthouse fundsAgainstApproved, 97.7% support
Alkermes plc2026-05-20To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended.AbstainFOR — 7 of 8 Brighthouse fundsAgainst—
Alkermes plc2026-05-20To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers.AbstainFOR — 7 of 8 Brighthouse fundsAgainstApproved, 98.7% support
Alkermes plc2026-05-20To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm's remuneration.AbstainFOR — 7 of 8 Brighthouse fundsAgainst—
Alkermes plc2026-05-20To renew Board authority to allot and issue shares under Irish law.AgainstFOR — 7 of 8 Brighthouse fundsAgainst—
Alkermes plc2026-05-20To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law.AgainstFOR — 7 of 8 Brighthouse fundsAgainst—
Sterling Infrastructure, Inc.2026-05-07Election of Directors: David S. SchulzAbstainFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 99.8% support
Sterling Infrastructure, Inc.2026-05-07Election of Directors: Joseph A. CutilloAbstainFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 99.5% support
Sterling Infrastructure, Inc.2026-05-07Election of Directors: Julie A. DillAbstainFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 99.7% support
Sterling Infrastructure, Inc.2026-05-07Election of Directors: Roger A. CreggAbstainFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 99.7% support
Sterling Infrastructure, Inc.2026-05-07To approve, on an advisory basis, the compensation of our named executive officers.AbstainFOR — 7 of 8 Brighthouse fundsAgainstApproved, 98.4% support
Sterling Infrastructure, Inc.2026-05-07To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2026.AbstainFOR — 7 of 8 Brighthouse fundsAgainstApproved, 98.1% support
Installed Building Products, Inc.2026-05-19Approval, on an advisory basis, of the compensation of our named executive officers.AbstainFOR — 7 of 8 Brighthouse fundsAgainstApproved, 97.3% support
Installed Building Products, Inc.2026-05-19Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2026.AbstainFOR — 7 of 8 Brighthouse fundsAgainstApproved, 99.6% support
Haemonetics Corporation2025-07-24Election of Directors: Charles J. DockendorffWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 97.1% support
Haemonetics Corporation2025-07-24Election of Directors: Christopher A. SimonWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 99.8% support
Haemonetics Corporation2025-07-24Election of Directors: Claire PomeroyWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 99.3% support
Haemonetics Corporation2025-07-24Election of Directors: Diane M. BryantWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 99.3% support
Haemonetics Corporation2025-07-24Election of Directors: Ellen M. ZaneWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 98.2% support
Haemonetics Corporation2025-07-24Election of Directors: Lloyd E. JohnsonWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 98.4% support
Haemonetics Corporation2025-07-24Election of Directors: Mark W. KrollWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 97.5% support
Haemonetics Corporation2025-07-24Election of Directors: Michael J. CoyleWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 99.6% support
Haemonetics Corporation2025-07-24Election of Directors: Robert E. AbernathyWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 98.2% support
Haemonetics Corporation2025-07-24To Ratify The Appointment Of Ernst & Young Llp As Our Independent Registered Public Accounting Firm For The Fiscal Year Ending March 28, 2026.AbstainFOR — 7 of 8 Brighthouse fundsAgainstApproved, 96.6% support
Haemonetics Corporation2025-07-24To approve, on an advisory basis, the compensation of our named executive officers.AbstainFOR — 7 of 8 Brighthouse fundsAgainstApproved, 98.7% support
PTC Therapeutics, Inc.2026-06-02Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement.AbstainFOR — 7 of 8 Brighthouse fundsAgainst—
PTC Therapeutics, Inc.2026-06-02Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 7 of 8 Brighthouse fundsAgainst—
Hamilton Lane Incorporated2025-09-04To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending March 31, 2026.AbstainFOR — 7 of 8 Brighthouse fundsAgainstApproved, 99.8% support
Novanta Inc.2026-05-28Approval, on an advisory (non-binding) basis, of the Company's executive compensation.AbstainFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 97.8% support
Novanta Inc.2026-05-28Election of Directors: Election of Director: Darlene J.S. Solomon, Ph.D.WithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 98.2% support
Novanta Inc.2026-05-28Election of Directors: Election of Director: Frank A. WilsonWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 99.8% support
Novanta Inc.2026-05-28Election of Directors: Election of Director: Lonny J. CarpenterWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 97.7% support
Novanta Inc.2026-05-28Election of Directors: Election of Director: Mary Katherine LadoneWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 97.8% support
Novanta Inc.2026-05-28Election of Directors: Election of Director: Matthew T. FarrellWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 99.9% support
Novanta Inc.2026-05-28Election of Directors: Election of Director: Matthijs GlastraWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 97.5% support
Novanta Inc.2026-05-28Election of Directors: Election of Director: Maxine L. MauricioWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 97.8% support
Novanta Inc.2026-05-28Election of Directors: Election of Director: R. Matthew JohnsonWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 98.3% support
Novanta Inc.2026-05-28Election of Directors: Election of Director: Thomas N. SecorWithholdFOR — 7 of 8 Brighthouse fundsAgainstPassed (calculated), 98.6% support
Novanta Inc.2026-05-28To appoint Deloitte and Touche LLP as the Company's independent registered public accounting firm to serve until the 2027 annual meeting of shareholders.AbstainFOR — 7 of 8 Brighthouse fundsAgainstApproved, 100.0% support
Oceaneering International, Inc.2026-05-15Advisory vote on a resolution to approve the compensation of our named executive officers.AbstainFOR — 7 of 8 Brighthouse fundsAgainstApproved, 97.2% support
Oceaneering International, Inc.2026-05-15Proposal to ratify the appointment of Ernst & Young LLP as our independent auditors for the year ending December 31, 2026.AbstainFOR — 7 of 8 Brighthouse fundsAgainstApproved, 97.7% support
Rambus Inc.2026-04-23Advisory vote to approve named executive officer compensation.AbstainFOR — 9 of 11 Brighthouse fundsAgainstPassed (calculated), 97.4% support
Rambus Inc.2026-04-23Election of Directors: Meera RaoAbstainFOR — 9 of 11 Brighthouse fundsAgainstPassed (calculated), 93.9% support
Rambus Inc.2026-04-23Election of Directors: Necip SayinerAbstainFOR — 9 of 11 Brighthouse fundsAgainstPassed (calculated), 93.5% support
Coeur Mining, Inc.2026-05-12Election of nine directors: Eduardo LunaAbstainFOR — 4 of 4 Brighthouse fundsAgainstElected, 99.8% support
Coeur Mining, Inc.2026-05-12Election of nine directors: J. Kenneth ThompsonAbstainFOR — 4 of 4 Brighthouse fundsAgainstElected, 92.6% support
Coeur Mining, Inc.2026-05-12Election of nine directors: Jeane L. HullAbstainFOR — 4 of 4 Brighthouse fundsAgainstElected, 96.0% support
Coeur Mining, Inc.2026-05-12Election of nine directors: Linda L. AdamanyAbstainFOR — 4 of 4 Brighthouse fundsAgainstElected, 92.9% support
Coeur Mining, Inc.2026-05-12Election of nine directors: Marilyn SchonbernerAbstainFOR — 4 of 4 Brighthouse fundsAgainstElected, 99.8% support
Coeur Mining, Inc.2026-05-12Election of nine directors: Mitchell J. KrebsAbstainFOR — 4 of 4 Brighthouse fundsAgainstElected, 92.7% support
Coeur Mining, Inc.2026-05-12Election of nine directors: Paramita DasAbstainFOR — 4 of 4 Brighthouse fundsAgainstElected, 97.4% support
Coeur Mining, Inc.2026-05-12Election of nine directors: Patrick GodinAbstainFOR — 4 of 4 Brighthouse fundsAgainstElected, 98.5% support
Coeur Mining, Inc.2026-05-12Election of nine directors: Pierre BeaudoinAbstainFOR — 4 of 4 Brighthouse fundsAgainstElected, 98.6% support
ImmunityBio, Inc.2026-06-09To ratify the selection of Deloitte & Touche LLP as ImmunityBio's independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 99.8% support
Praxis Precision Medicines, Inc.2026-06-10To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Gregory NordenWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 98.8% support
Praxis Precision Medicines, Inc.2026-06-10To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Marcio SouzaWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 99.5% support
Ionis Pharmaceuticals, Inc.2026-06-04To approve an amendment of the Amended and Restated 2000 Employee Stock Purchase Plan to increase the number of shares of common stock authorized for purchase under such plan by 750,000 shares and remove the termination date of the plan.AgainstFOR — 4 of 4 Brighthouse fundsAgainstApproved, 99.8% support
Ionis Pharmaceuticals, Inc.2026-06-04To approve an amendment of the Amended and Restated Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 9,500,000 shares to an aggregate of 52,000,000 shares.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 77.0% support
Ionis Pharmaceuticals, Inc.2026-06-04To make an advisory vote on executive compensation.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 96.4% support
Ionis Pharmaceuticals, Inc.2026-06-04To ratify the Audit Committee's selection of Ernst & Young LLP as independent auditors for the 2026 fiscal year.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 97.4% support
VSE Corporation2026-05-07Approval of an amendment to the Company's Restated Certificate of Incorporation to authorize the issuance of blank check preferred stock.AgainstFOR — 4 of 4 Brighthouse fundsAgainstApproved, 83.8% support
VSE Corporation2026-05-07Ratification of the appointment of Grant Thornton LLP as VSE's independent registered public accounting firm for the year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 99.9% support
iRhythm Holdings, Inc.2026-05-27To approve the adoption of the Amended and Restated Certificate of Incorporation of iRhythm Technologies, Inc. to remove the pass-through voting provision.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 99.9% support
iRhythm Holdings, Inc.2026-05-27To approve, on a non-binding advisory basis, the named executive officer compensation.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 98.4% support
iRhythm Holdings, Inc.2026-05-27To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 99.9% support
Tutor Perini Corporation2026-05-20Approve the compensation of the Company's named executive officers on an advisory (non-binding) basis.AbstainFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 97.6% support
Tutor Perini Corporation2026-05-20Ratify the appointment of Deloitte & Touche LLP as independent auditor of the Company for the year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 98.0% support
Scorpio Tankers Inc.2026-05-27Election of Director: Antonino MattarellaWithholdFOR — 4 of 4 Brighthouse fundsAgainst—
Scorpio Tankers Inc.2026-05-27Election of Director: Emanuele A. LauroWithholdFOR — 4 of 4 Brighthouse fundsAgainst—
Core Scientific, Inc.2026-05-12To ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 99.9% support
ACADIA Pharmaceuticals Inc.2026-05-29To approve an amendment to the Company's 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 5,209,670 shares.AbstainFOR — 4 of 4 Brighthouse fundsAgainst—
ACADIA Pharmaceuticals Inc.2026-05-29To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 98.7% support
ACADIA Pharmaceuticals Inc.2026-05-29To ratify the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 97.9% support
Disc Medicine, Inc.2026-06-18To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 98.9% support
Disc Medicine, Inc.2026-06-18To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 100.0% support
American Eagle Outfitters, Inc.2026-06-26Approve an amendment and restatement of the Company's 2023 Stock Award and Incentive Plan to increase the number of authorized shares thereunder.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 96.5% support
American Eagle Outfitters, Inc.2026-06-26Election of Class I Director: Jay L. SchottensteinAbstainFOR — 4 of 4 Brighthouse fundsAgainstElected, 86.9% support
American Eagle Outfitters, Inc.2026-06-26Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending January 31, 2027.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 94.3% support
OneSpaWorld Holdings Limited2026-06-03Approval of the OneSpaWorld Holdings Limited Amended and Restated 2019 Equity Incentive Plan.AbstainFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 95.9% support
OneSpaWorld Holdings Limited2026-06-03Approval, by non-binding advisory vote, of the compensation of the company's named executive officers.AbstainFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 95.0% support
OneSpaWorld Holdings Limited2026-06-03Election of Directors: Adam HasibaWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 97.1% support
OneSpaWorld Holdings Limited2026-06-03Election of Directors: Glenn J. FusfieldWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 90.8% support
OneSpaWorld Holdings Limited2026-06-03Election of Directors: Leonard FluxmanWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 94.5% support
OneSpaWorld Holdings Limited2026-06-03Election of Directors: Stephen W. PowellWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 96.6% support
OneSpaWorld Holdings Limited2026-06-03Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 99.4% support
Skyward Specialty Insurance Group, Inc.2026-05-05The approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 93.5% support
Skyward Specialty Insurance Group, Inc.2026-05-05The ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 99.2% support
Axcelis Technologies, Inc.2026-05-05Proposal to ratify independent public accounting firm.AbstainFOR — 4 of 4 Brighthouse fundsAgainst—
Axcelis Technologies, Inc.2026-05-05Say on Pay - An advisory vote on the approval of executive compensation.AbstainFOR — 4 of 4 Brighthouse fundsAgainst—
Ambarella, Inc.2026-06-26Election of Directors: Gregory M. BryantWithholdFOR — 4 of 4 Brighthouse fundsAgainstElected, 99.4% support
Navitas Semiconductor Corporation2026-06-25The ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 99.6% support
Biohaven Ltd.2026-04-28A non-binding advisory vote on the compensation of the Company's named executive officers.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 95.4% support
Biohaven Ltd.2026-04-28Ratification of appointment of Ernst & Young LLP as independent auditors for fiscal year 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 99.8% support
Energy Fuels Inc.2026-06-24Election of Directors: Barbara A. FilasWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 98.1% support
Energy Fuels Inc.2026-06-24Election of Directors: Benjamin Eshleman IIIWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 88.6% support
Energy Fuels Inc.2026-06-24Election of Directors: Bruce D. HansenWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 97.1% support
Energy Fuels Inc.2026-06-24Election of Directors: Dennis L. HiggsWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 89.0% support
Energy Fuels Inc.2026-06-24Election of Directors: Jaqueline HerreraWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 98.4% support
Energy Fuels Inc.2026-06-24Election of Directors: Ross R. BhappuWithholdFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 99.2% support
Stoke Therapeutics, Inc2026-06-03To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 100.0% support
Pursuit Attractions and Hospitality, Inc.2026-06-04Approve, on an advisory basis, the compensation of our named executive officers.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 98.4% support
Pursuit Attractions and Hospitality, Inc.2026-06-04Ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 99.3% support
Adient plc2026-03-10To approve, on an advisory basis, our named executive officer compensation.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 94.1% support
Universal Insurance Holdings, Inc.2026-06-11Advisory vote to approve the compensation of the Company's named executive officers as disclosed in the 2026 Proxy Statement.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 98.0% support
Universal Insurance Holdings, Inc.2026-06-11Ratification of the appointment of Plante & Moran, PLLC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 98.5% support
Vistance Networks, Inc.2026-05-07Non-binding, advisory vote to approve the frequency of future advisory votes on compensation of our named executive officers.AbstainFOR — 4 of 4 Brighthouse fundsAgainst—
Ivanhoe Electric Inc.2026-06-04Election of Directors: Hirofumi KataseAbstainFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 99.6% support
Ivanhoe Electric Inc.2026-06-04Election of Directors: Patrick Loftus-HillsAbstainFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 99.7% support
Ivanhoe Electric Inc.2026-06-04Election of Directors: Robert FriedlandAbstainFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 98.0% support
Ivanhoe Electric Inc.2026-06-04Election of Directors: Ronald VanceAbstainFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 99.3% support
Ivanhoe Electric Inc.2026-06-04Election of Directors: Russell BallAbstainFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 97.4% support
Ivanhoe Electric Inc.2026-06-04Election of Directors: Taylor MelvinAbstainFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 99.7% support
Ivanhoe Electric Inc.2026-06-04Election of Directors: Victoire de MargerieAbstainFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 99.8% support
First Financial Corporation2026-04-15Approve, by non-binding vote, compensation paid to the Corporation's named executive officers.AbstainFOR — 4 of 4 Brighthouse fundsAgainst—
First Financial Corporation2026-04-15Ratification of the appointment of Crowe LLP as the independent registered public accounting firm for the Corporation for the fiscal year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainst—
Corvus Pharmaceuticals, Inc.2026-06-11To approve, on a non-binding advisory basis, the compensation of our named executive officers.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 96.8% support
Corvus Pharmaceuticals, Inc.2026-06-11To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 99.9% support
SmartFinancial, Inc.2026-05-21To approve, on a non-binding advisory basis, the compensation of SmartFinancial's named executive officers as listed in these proxy materials.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 97.1% support
SmartFinancial, Inc.2026-05-21To ratify the appointment of Elliott Davis, PLLC as the company's independent registered public accountants for the fiscal year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 100.0% support
ProPetro Holding Corp.2026-05-19Approval, on an advisory basis, of the compensation of our named executive officersAbstainFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 98.6% support
ProPetro Holding Corp.2026-05-19Ratification of the appointment of RSM US LLP as our independent, registered public accounting firm for the fiscal year ending December 31, 2026AbstainFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 100.0% support
WAVE Life Sciences Ltd.2025-08-05To approve the re-appointment of KPMG LLP to serve as our independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2025, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP's remuneration for services provided throughAbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 99.6% support
WAVE Life Sciences Ltd.2025-08-05To approve, on a non-binding, advisory basis only, the frequency of holding future shareholder advisory votes on the compensation of our named executive officers.AbstainFOR — 4 of 4 Brighthouse fundsAgainst—
NetGear, Inc.2026-05-28Proposal to approve, on a non-binding advisory basis, a resolution approving the compensation of our Named Executive Officers in the Proxy Statement.AbstainFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 97.9% support
NetGear, Inc.2026-05-28Proposal to ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainstPassed (calculated), 97.9% support
Akero Therapeutics, Inc.2025-12-02To approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of the adoption of the Merger Agreement at the time of the special meeting.AbstainFOR — 4 of 4 Brighthouse fundsAgainst—
Akero Therapeutics, Inc.2025-12-02To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger.AbstainFOR — 4 of 4 Brighthouse fundsAgainstApproved, 98.0% support
Omada Health, Inc.2026-06-16The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 4 of 4 Brighthouse fundsAgainst—
Watts Water Technologies, Inc.2026-05-19Advisory vote to approve named executive officer compensation.AbstainFOR — 6 of 7 Brighthouse fundsAgainstApproved, 98.3% support
Watts Water Technologies, Inc.2026-05-19To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 6 of 7 Brighthouse fundsAgainstApproved, 97.0% support
Pool Corporation2026-04-29Ratification of the retention of Ernst & Young LLP, certified public accountants, as our independent registered public accounting firm for the 2026 fiscal year.AbstainFOR — 8 of 10 Brighthouse fundsAgainstApproved, 96.5% support
Pool Corporation2026-04-29Say-on-pay vote: Advisory vote to approve the compensation of our named executive officers as disclosed in the proxy statement.AbstainFOR — 8 of 10 Brighthouse fundsAgainstApproved, 94.9% support
Advanced Energy Industries, Inc.2026-05-07Election of ten (10) directors: Anne T. DelSantoWithholdFOR — 8 of 10 Brighthouse fundsAgainstElected, 98.5% support
Advanced Energy Industries, Inc.2026-05-07Election of ten (10) directors: Brian M. ShirleyWithholdFOR — 8 of 10 Brighthouse fundsAgainstElected, 99.7% support
Advanced Energy Industries, Inc.2026-05-07Election of ten (10) directors: David W. ReedWithholdFOR — 8 of 10 Brighthouse fundsAgainstElected, 99.7% support
Advanced Energy Industries, Inc.2026-05-07Election of ten (10) directors: Frederick A. BallWithholdFOR — 8 of 10 Brighthouse fundsAgainstElected, 97.6% support
Advanced Energy Industries, Inc.2026-05-07Election of ten (10) directors: Grant H. BeardWithholdFOR — 8 of 10 Brighthouse fundsAgainstElected, 98.3% support
Advanced Energy Industries, Inc.2026-05-07Election of ten (10) directors: John A. RoushWithholdFOR — 8 of 10 Brighthouse fundsAgainstElected, 96.5% support
Advanced Energy Industries, Inc.2026-05-07Election of ten (10) directors: Lanesha T. MinnixWithholdFOR — 8 of 10 Brighthouse fundsAgainstElected, 98.3% support
Advanced Energy Industries, Inc.2026-05-07Election of ten (10) directors: Ronald C. FosterWithholdFOR — 8 of 10 Brighthouse fundsAgainstElected, 98.0% support
Advanced Energy Industries, Inc.2026-05-07Election of ten (10) directors: Stephen D. KelleyWithholdFOR — 8 of 10 Brighthouse fundsAgainstElected, 98.6% support
Advanced Energy Industries, Inc.2026-05-07Election of ten (10) directors: Tina M. DonikowskiWithholdFOR — 8 of 10 Brighthouse fundsAgainstElected, 97.6% support
InterDigital, Inc.2026-06-10Advisory resolution to approve executive compensation.AbstainFOR — 6 of 7 Brighthouse fundsAgainstPassed (calculated), 98.5% support
InterDigital, Inc.2026-06-10Approval of bylaws amendment to allow for officer exculpation as permitted by Pennsylvania law.AbstainFOR — 6 of 7 Brighthouse fundsAgainstPassed (calculated), 93.0% support
InterDigital, Inc.2026-06-10Election of Directors: Derek K. AberleAbstainFOR — 6 of 7 Brighthouse fundsAgainstElected, 99.8% support
InterDigital, Inc.2026-06-10Election of Directors: Jean F. RankinAbstainFOR — 6 of 7 Brighthouse fundsAgainstElected, 97.6% support
InterDigital, Inc.2026-06-10Election of Directors: Joan H. GillmanAbstainFOR — 6 of 7 Brighthouse fundsAgainstElected, 97.4% support
InterDigital, Inc.2026-06-10Election of Directors: John A. KritzmacherAbstainFOR — 6 of 7 Brighthouse fundsAgainstElected, 96.8% support
InterDigital, Inc.2026-06-10Election of Directors: John D. Markley, Jr.AbstainFOR — 6 of 7 Brighthouse fundsAgainstElected, 91.5% support
InterDigital, Inc.2026-06-10Election of Directors: Lawrence (Liren) ChenAbstainFOR — 6 of 7 Brighthouse fundsAgainstElected, 99.6% support
InterDigital, Inc.2026-06-10Election of Directors: S. Douglas HutchesonAbstainFOR — 6 of 7 Brighthouse fundsAgainstElected, 98.5% support
InterDigital, Inc.2026-06-10Election of Directors: Samir ArmalyAbstainFOR — 6 of 7 Brighthouse fundsAgainstElected, 98.4% support
InterDigital, Inc.2026-06-10Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm of InterDigital, Inc. for the year ending December 31, 2026.AbstainFOR — 6 of 7 Brighthouse fundsAgainstApproved, 98.3% support
Lantheus Holdings, Inc.2026-04-30The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 6 of 7 Brighthouse fundsAgainstApproved, 99.6% support
Commvault Systems, Inc.2025-08-07To approve additional shares to be available for grant under Commvault's 2016 Omnibus Incentive Plan.AbstainFOR — 8 of 10 Brighthouse fundsAgainstPassed (calculated), 95.4% support
Commvault Systems, Inc.2025-08-07To approve, on an advisory basis, Commvault's executive compensation.AbstainFOR — 8 of 10 Brighthouse fundsAgainstPassed (calculated), 96.2% support
Commvault Systems, Inc.2025-08-07To ratify the appointment of Ernst & Young LLP as Commvault's independent public accountants for the fiscal year ending March 31, 2026.AbstainFOR — 8 of 10 Brighthouse fundsAgainstPassed (calculated), 94.4% support
Commvault Systems, Inc.2025-08-07To re-elect the Directors for a one-year term: Allison PickensAbstainFOR — 8 of 10 Brighthouse fundsAgainstPassed (calculated), 99.0% support
Commvault Systems, Inc.2025-08-07To re-elect the Directors for a one-year term: Arlen ShenkmanAbstainFOR — 8 of 10 Brighthouse fundsAgainstPassed (calculated), 99.9% support
Commvault Systems, Inc.2025-08-07To re-elect the Directors for a one-year term: Chuck MoranAbstainFOR — 8 of 10 Brighthouse fundsAgainstPassed (calculated), 99.9% support
Commvault Systems, Inc.2025-08-07To re-elect the Directors for a one-year term: Keith GeeslinAbstainFOR — 8 of 10 Brighthouse fundsAgainstPassed (calculated), 97.8% support
Commvault Systems, Inc.2025-08-07To re-elect the Directors for a one-year term: Martha BejarAbstainFOR — 8 of 10 Brighthouse fundsAgainstPassed (calculated), 98.2% support
Commvault Systems, Inc.2025-08-07To re-elect the Directors for a one-year term: Nicola AdamoAbstainFOR — 8 of 10 Brighthouse fundsAgainstPassed (calculated), 99.1% support
Commvault Systems, Inc.2025-08-07To re-elect the Directors for a one-year term: Sanjay MirchandaniAbstainFOR — 8 of 10 Brighthouse fundsAgainstPassed (calculated), 100.0% support
Commvault Systems, Inc.2025-08-07To re-elect the Directors for a one-year term: Shane SandersAbstainFOR — 8 of 10 Brighthouse fundsAgainstPassed (calculated), 98.3% support
Weatherford International plc2026-06-11Election of Directors: Benjamin C. Duster, IVAbstainFOR — 6 of 7 Brighthouse fundsAgainstPassed (calculated), 88.5% support
Weatherford International plc2026-06-11Election of Directors: Charles M. SledgeAbstainFOR — 6 of 7 Brighthouse fundsAgainstPassed (calculated), 96.5% support
Weatherford International plc2026-06-11Election of Directors: Girishchandra K. SaligramAbstainFOR — 6 of 7 Brighthouse fundsAgainstPassed (calculated), 99.9% support
Weatherford International plc2026-06-11Election of Directors: Jacqueline C. MutschlerAbstainFOR — 6 of 7 Brighthouse fundsAgainstPassed (calculated), 88.5% support
Weatherford International plc2026-06-11Election of Directors: Neal P. GoldmanAbstainFOR — 6 of 7 Brighthouse fundsAgainstPassed (calculated), 81.9% support
Weatherford International plc2026-06-11Election of Directors: Steven BeringhauseAbstainFOR — 6 of 7 Brighthouse fundsAgainstPassed (calculated), 99.6% support
Weatherford International plc2026-06-11To approve a renewal of the Board's annual authority to issue shares under Irish law.AgainstFOR — 6 of 7 Brighthouse fundsAgainstPassed (calculated), 99.6% support
Weatherford International plc2026-06-11To approve a renewal of the Board's annual power to opt-out of statutory preemption rights under Irish law.AgainstFOR — 6 of 7 Brighthouse fundsAgainstPassed (calculated), 99.4% support
Weatherford International plc2026-06-11To approve the amendment and restatement of the Weatherford International plc Fourth Amended and Restated 2019 Equity Incentive Plan.AbstainFOR — 6 of 7 Brighthouse fundsAgainst—
Weatherford International plc2026-06-11To approve, on a non-binding advisory basis, the compensation of our named executive officers.AbstainFOR — 6 of 7 Brighthouse fundsAgainstPassed (calculated), 99.2% support
Weatherford International plc2026-06-11To ratify the appointment of KPMG LLP as our independent registered public accounting firm and auditor for the fiscal year ending December 31, 2026 and KPMG Chartered Accountants, Dublin, as our statutory auditor under Irish law to hold office until the close of the 2027 AGM, and to authorize our BoAbstainFOR — 6 of 7 Brighthouse fundsAgainstPassed (calculated), 99.3% support
Option Care Health, Inc.2026-05-20To approve, on a non-binding advisory basis, our executive compensation.AbstainFOR — 6 of 7 Brighthouse fundsAgainstApproved, 97.1% support
Option Care Health, Inc.2026-05-20To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026.AbstainFOR — 6 of 7 Brighthouse fundsAgainstApproved, 99.2% support
UFP Industries, Inc.2026-04-22To approve, on an advisory (non-binding) basis, the compensation paid to our Named Executives.AbstainFOR — 6 of 7 Brighthouse fundsAgainstApproved, 96.4% support
UFP Industries, Inc.2026-04-22To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal 2026.AbstainFOR — 6 of 7 Brighthouse fundsAgainstApproved, 99.6% support
The Vita Coco Company, Inc.2026-06-03Advisory vote on executive compensation.AbstainFOR — 6 of 7 Brighthouse fundsAgainstApproved, 95.4% support
Oceaneering International, Inc.2026-05-15Election of Class I Directors: William B. BerryWithholdFOR — 6 of 7 Brighthouse fundsAgainstElected, 96.9% support
Knife River Corporation2026-05-20Advisory Vote to Approve the Compensation Paid to the Company's Named Executive Officers.AbstainFOR — 6 of 7 Brighthouse fundsAgainstApproved, 96.2% support
Knife River Corporation2026-05-20Election of Two Class III Directors: Brian R. GrayAbstainFOR — 6 of 7 Brighthouse fundsAgainstElected, 99.9% support
Knife River Corporation2026-05-20Election of Two Class III Directors: Karen B. FaggAbstainFOR — 6 of 7 Brighthouse fundsAgainstElected, 95.2% support
Knife River Corporation2026-05-20Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for 2026.AbstainFOR — 6 of 7 Brighthouse fundsAgainstApproved, 96.6% support
Stride, Inc.2025-12-04Approval of the Company's 2025 Employee Stock Purchase Plan; andAgainstFOR — 6 of 7 Brighthouse fundsAgainst—
Stride, Inc.2025-12-04Elect eight (8) directors to the Company's Board of Directors each to serve for a one-year term: James J. RhyuWithholdFOR — 6 of 7 Brighthouse fundsAgainstElected, 94.0% support
Kymera Therapeutics, Inc.2026-06-24To approve, on a non-binding advisory basis, the compensation of our named executive officers; andAbstainFOR — 7 of 9 Brighthouse fundsAgainstApproved, 96.8% support
Kymera Therapeutics, Inc.2026-06-24To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 7 of 9 Brighthouse fundsAgainstApproved, 100.0% support
Pool Corporation2026-04-29Election of Directors: David G. WhalenAbstainFOR — 7 of 9 Brighthouse fundsAgainstElected, 87.4% support
Pool Corporation2026-04-29Election of Directors: Debra S. OlerAbstainFOR — 7 of 9 Brighthouse fundsAgainstElected, 99.5% support
Pool Corporation2026-04-29Election of Directors: John E. StokelyAbstainFOR — 7 of 9 Brighthouse fundsAgainstElected, 96.3% support
Pool Corporation2026-04-29Election of Directors: Kevin M. MurphyAbstainFOR — 7 of 9 Brighthouse fundsAgainstElected, 99.4% support
Pool Corporation2026-04-29Election of Directors: Manuel J. Perez de la MesaAbstainFOR — 7 of 9 Brighthouse fundsAgainstElected, 99.0% support
Pool Corporation2026-04-29Election of Directors: Mark A. PompaAbstainFOR — 7 of 9 Brighthouse fundsAgainstElected, 99.3% support
Pool Corporation2026-04-29Election of Directors: Peter D. ArvanAbstainFOR — 7 of 9 Brighthouse fundsAgainstElected, 99.1% support
ESCO Technologies Inc.2026-01-30Election of Directors: Patrick M. DewarWithholdFOR — 7 of 9 Brighthouse fundsAgainstElected, 96.4% support
ESCO Technologies Inc.2026-01-30Election of Directors: Vinod M. KhilnaniWithholdFOR — 7 of 9 Brighthouse fundsAgainstElected, 96.6% support
Modine Manufacturing Company2025-08-21Election of Directors: Mr. David J. WilsonAbstainFOR — 7 of 9 Brighthouse fundsAgainstPassed (calculated), 91.6% support
Modine Manufacturing Company2025-08-21Election of Directors: Ms. Katherine C. HarperAbstainFOR — 7 of 9 Brighthouse fundsAgainstPassed (calculated), 95.5% support
Nuvalent, Inc.2026-06-16To approve, on an advisory basis, the compensation paid to our named executive officers.AbstainFOR — 7 of 9 Brighthouse fundsAgainstApproved, 97.5% support
Nextracker Inc.2025-08-18The approval, on an advisory basis, of the compensation of our named executive officers.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 80.4% support
Tetra Tech, Inc.2026-02-19Election of Directors: Dan L. BatrackAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 95.9% support
Tetra Tech, Inc.2026-02-19Election of Directors: Gary R. BirkenbeuelAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 96.7% support
Tetra Tech, Inc.2026-02-19Election of Directors: Jeffrey R. FeelerAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 97.8% support
Tetra Tech, Inc.2026-02-19Election of Directors: Kirsten M. VolpiAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 92.9% support
Tetra Tech, Inc.2026-02-19Election of Directors: M. Susan HardwickAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 98.2% support
Tetra Tech, Inc.2026-02-19Election of Directors: Prashant GandhiAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 87.2% support
Tetra Tech, Inc.2026-02-19To approve the Amendment to the Employee Stock Purchase Plan.AgainstFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 99.5% support
Tetra Tech, Inc.2026-02-19To approve, on an advisory basis, the Company's named executive officers' compensation.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 92.7% support
Tetra Tech, Inc.2026-02-19To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal year 2026.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 91.5% support
Oscar Health, Inc.2026-06-04Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 99.9% support
Hecla Mining Company2026-05-21Advisory resolution to approve our named executive officer compensation for 2025.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 95.5% support
Hecla Mining Company2026-05-21Proposal to ratify and approve the selection of BDO USA, P.C., as our independent registered public accounting firm for the calendar year ending December 31, 2026.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 91.9% support
Old National Bancorp2026-05-13Approval of a non-binding advisory proposal on the compensation of the Company's named executive officers.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 97.0% support
Old National Bancorp2026-05-13Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2026.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 99.8% support
Henry Schein, Inc.2026-05-21Shareholder Proposal to approve, by non-binding vote, a shareholder proposal to Govern by Majority Vote.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 57.6% support
Henry Schein, Inc.2026-05-21Proposal to approve, by non-binding vote, the 2025 compensation paid to the Company's Named Executive Officers.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 98.0% support
Henry Schein, Inc.2026-05-21Proposal to ratify the selection of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 26, 2026.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 98.3% support
ImmunityBio, Inc.2026-06-09Election of Directors: Barry J. Simon, M.D.WithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 99.7% support
ImmunityBio, Inc.2026-06-09Election of Directors: Bruce WendelWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 99.8% support
ImmunityBio, Inc.2026-06-09Election of Directors: Cheryl L. CohenWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 99.7% support
ImmunityBio, Inc.2026-06-09Election of Directors: Richard AdcockWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 99.8% support
ImmunityBio, Inc.2026-06-09Election of Directors: Wesley ClarkWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 99.4% support
Caris Life Sciences, Inc.2026-06-04To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 100.0% support
Sanmina Corporation2026-03-09To ratify the appointment of PricewaterhouseCoopers LLP as Sanmina Corporation's independent registered public accounting firm for the fiscal year ending October 3, 2026.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 98.9% support
Federal Signal Corporation2026-04-21Approve, on an advisory basis, the compensation of our named executive officers.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 92.3% support
Federal Signal Corporation2026-04-21Ratify the appointment of Deloitte & Touche LLP as Federal Signal Corporation's independent registered public accounting firm for fiscal year 2026.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 99.3% support
StoneX Group Inc.2026-03-10To approve the advisory (non-binding) resolution relating to executive compensation.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 89.6% support
StoneX Group Inc.2026-03-10To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the 2026 fiscal year.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 99.5% support
Vicor Corporation2026-06-19Advisory vote to approve the compensation of the Corporation's named executive officers.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 99.8% support
Fluor Corporation2026-05-06An advisory vote to approve the company's executive compensation.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 87.5% support
Fluor Corporation2026-05-06The ratification of the appointment by our Audit Committee of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 97.5% support
IES Holdings, Inc.2026-02-19Advisory Vote To Approve Named Executive Officer Compensation.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 92.8% support
IES Holdings, Inc.2026-02-19Ratification Of Appointment Of Ernst & Young Llp As Auditors For The Company For Fiscal Year 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 99.4% support
Dycom Industries, Inc.2026-05-28Election of Directors: Philip R. GallagherAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 99.7% support
Dycom Industries, Inc.2026-05-28Election of Directors: Raejeanne SkillernAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 99.8% support
Dycom Industries, Inc.2026-05-28Election of Directors: Stephen O. LeClairAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 99.7% support
Dycom Industries, Inc.2026-05-28To approve, by non-binding advisory vote, executive compensation.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 97.0% support
Dycom Industries, Inc.2026-05-28To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal 2027.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 99.6% support
Hims & Hers Health, Inc.2026-06-11Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 100.0% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11To approve a non-binding advisory proposal regarding named executive officer compensation.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 98.2% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending January 30, 2027.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 99.4% support
Joby Aviation, Inc.2026-06-02Approval, in a non-binding advisory vote, of the compensation of Joby's named executive officers.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 98.6% support
Joby Aviation, Inc.2026-06-02Ratify the appointment of PricewaterhouseCoopers LLP as Joby's independent registered public accounting firm for fiscal year 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.5% support
Cogent Biosciences, Inc.2026-06-09Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 90.2% support
Cogent Biosciences, Inc.2026-06-09Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.7% support
TeraWulf Inc.2026-06-09The ratification of the appointment of Deloitte & Touche LLP as the Company's Independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 99.8% support
Herc Holdings Inc.2026-05-14Approval, by a non-binding advisory vote, of the named executive officers' compensation.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 97.7% support
Herc Holdings Inc.2026-05-14Election of the eight nominees named in the Company's proxy statement to serve as directors until the next Annual Meeting of Stockholders: John A. OlinAbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.9% support
Herc Holdings Inc.2026-05-14Election of the eight nominees named in the Company's proxy statement to serve as directors until the next Annual Meeting of Stockholders: Lawrence H. SilberAbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.8% support
Herc Holdings Inc.2026-05-14Election of the eight nominees named in the Company's proxy statement to serve as directors until the next Annual Meeting of Stockholders: Patrick S. ShannonAbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.9% support
Herc Holdings Inc.2026-05-14Election of the eight nominees named in the Company's proxy statement to serve as directors until the next Annual Meeting of Stockholders: Shari L. BurgessAbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.8% support
Herc Holdings Inc.2026-05-14Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 99.8% support
Impinj, Inc.2026-05-28To approve, on an advisory basis, the compensation of our named executive officers.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 96.0% support
Impinj, Inc.2026-05-28To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 99.9% support
Travere Therapeutics Inc.2026-05-19To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.AbstainFOR — 3 of 3 Brighthouse fundsAgainst—
Badger Meter, Inc.2026-04-24Advisory Vote To Approve Compensation Of Our Named Executive Officers.AbstainFOR — 5 of 6 Brighthouse fundsAgainst—
Badger Meter, Inc.2026-04-24Ratification Of The Appointment Of Ernst & Young Llp As Independent Registered Public Accountants For 2026.AbstainFOR — 5 of 6 Brighthouse fundsAgainst—
The Brink's Company2026-04-28Approval of a non-binding advisory resolution on named executive officer compensation.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 98.8% support
The Brink's Company2026-04-28Approval of the Company's amended and restated 2024 Equity Incentive Plan.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 97.2% support
The Brink's Company2026-04-28Election of Directors: A. Louis ParkerAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 98.3% support
The Brink's Company2026-04-28Election of Directors: Ian D. CloughAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 98.7% support
The Brink's Company2026-04-28Election of Directors: Kathie J. AndradeAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 93.7% support
The Brink's Company2026-04-28Election of Directors: Keith R. WycheAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 98.3% support
The Brink's Company2026-04-28Election of Directors: Mark EubanksAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 98.9% support
The Brink's Company2026-04-28Election of Directors: Michael J. HerlingAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 97.3% support
The Brink's Company2026-04-28Election of Directors: Paul G. BoyntonAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 98.0% support
The Brink's Company2026-04-28Election of Directors: Susan E. DochertyAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 98.1% support
The Brink's Company2026-04-28Election of Directors: Timothy J. TynanAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 99.3% support
The Brink's Company2026-04-28Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 99.8% support
Iridium Communications Inc.2026-05-20Advisory vote to approve the compensation of Iridium Communications Inc.'s named executive officersAbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 86.8% support
Iridium Communications Inc.2026-05-20Approval of the Iridium Communications Inc. Amended and Restated 2015 Equity Incentive PlanAbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 90.9% support
Iridium Communications Inc.2026-05-20Ratification of the selection of KPMG LLP as Iridium Communications Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2026AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 99.9% support
Construction Partners, Inc.2026-03-24Proposal to ratify the appointment of RSM US LLP as the Company's independent registered public accountants for the fiscal year ending September 30, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.8% support
Enova International, Inc.2026-05-13A non-binding advisory vote to approve the compensation paid to the Company's named executive officers.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 95.5% support
Enova International, Inc.2026-05-13Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the Company's fiscal year ending December 31, 2026.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 100.0% support
Tutor Perini Corporation2026-05-20Election of Directors: Dale Anne ReissAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 97.4% support
Tutor Perini Corporation2026-05-20Election of Directors: Dennis D. OklakAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 99.1% support
Tutor Perini Corporation2026-05-20Election of Directors: Gary G. SmalleyAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.9% support
Tutor Perini Corporation2026-05-20Election of Directors: Jigisha DesaiAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 90.6% support
Tutor Perini Corporation2026-05-20Election of Directors: Peter ArkleyAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 97.8% support
Tutor Perini Corporation2026-05-20Election of Directors: Raymond R. OnegliaAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 95.9% support
Tutor Perini Corporation2026-05-20Election of Directors: Robert C. LieberAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.1% support
Tutor Perini Corporation2026-05-20Election of Directors: Ronald N. TutorAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 97.7% support
Tutor Perini Corporation2026-05-20Election of Directors: Sidney J. FeltensteinAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.3% support
Korn Ferry2025-09-18Election of Directors: Angel R. MartinezAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 99.9% support
Korn Ferry2025-09-18Election of Directors: Gary D. BurnisonAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 99.6% support
Korn Ferry2025-09-18Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the Company's 2026 fiscal year.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 96.9% support
Applied Optoelectronics, Inc.2026-06-04To approve an adjournment of the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, one or more of the other proposals to be voted on at the AnnuAbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 93.9% support
Applied Optoelectronics, Inc.2026-06-04To approve the amendment of our Amended and Restated Certificate of Incorporation, as amended, to clarify the voting standard that applies to certain future amendments.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.2% support
Applied Optoelectronics, Inc.2026-06-04To approve, on an advisory basis, the compensation of our named executive officers.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 98.3% support
Liquidia Corporation2026-06-16Election of Directors: David JohnsonWithholdFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.9% support
Liquidia Corporation2026-06-16To approve, on an advisory basis, the compensation of our named executive officers.AbstainFOR — 3 of 3 Brighthouse fundsAgainst—
Liquidia Corporation2026-06-16To ratify the Appointment of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the Year Ending December 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.7% support
Magnite, Inc.2026-06-08Approval, on an advisory basis, of the compensation of the Company's named executive officers.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 89.2% support
Magnite, Inc.2026-06-08Election of Class III Directors: David PearsonAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 95.3% support
Magnite, Inc.2026-06-08Election of Class III Directors: Doug KnopperAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 92.8% support
Magnite, Inc.2026-06-08Election of Class III Directors: Paul CaineAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 95.0% support
Magnite, Inc.2026-06-08Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the current fiscal year.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 99.8% support
Solaris Energy Infrastructure, Inc.2026-05-15Ratify the appointment of BDO USA, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.6% support
MYR Group Inc.2026-04-23Advisory Approval Of The Compensation Of Our Named Executive Officers.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 97.8% support
MYR Group Inc.2026-04-23Ratification Of The Appointment Of Our Independent Registered Public Accounting Firm.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 99.4% support
Patterson-UTI Energy, Inc.2026-06-04Approval of the amendment to Patterson-UTI's 2021 Long-Term Incentive Plan.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 97.7% support
Patterson-UTI Energy, Inc.2026-06-04Approval, on an advisory basis, of Patterson-UTI's compensation of its named executive officers.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 95.2% support
Patterson-UTI Energy, Inc.2026-06-04Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Patterson-UTI for the fiscal year ending December 31, 2026.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 97.0% support
Core Scientific, Inc.2026-05-12Election of Directors: Adam SullivanWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.9% support
Core Scientific, Inc.2026-05-12Election of Directors: Elizabeth CrainWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 97.7% support
Nicolet Bankshares, Inc.2026-01-26Adjournment. A proposal to approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies to approve the merger agreement and the transactions contemplated by the merger agreement.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 98.3% support
Nicolet Bankshares, Inc.2026-05-18Ratification of the selection of Forvis Mazars, LLP as Nicolet's Independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.8% support
Tidewater Inc.2026-06-16Approve the First Amendment to the Company's Amended and Restated 2021 Stock Incentive Plan to increase the maximum number of shares of common stock available for issuance by 2,250,000.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 95.3% support
Tidewater Inc.2026-06-16Election of Directors - To elect seven (7) directors each for a one-year term: Dick H. FagerstalAbstainFOR — 5 of 6 Brighthouse fundsAgainstElected, 96.6% support
Tidewater Inc.2026-06-16Election of Directors - To elect seven (7) directors each for a one-year term: Kenneth H. TraubAbstainFOR — 5 of 6 Brighthouse fundsAgainstElected, 94.8% support
Tidewater Inc.2026-06-16Election of Directors - To elect seven (7) directors each for a one-year term: Lois K. ZabrockyAbstainFOR — 5 of 6 Brighthouse fundsAgainstElected, 99.8% support
Tidewater Inc.2026-06-16Election of Directors - To elect seven (7) directors each for a one-year term: Louis A. RaspinoAbstainFOR — 5 of 6 Brighthouse fundsAgainstElected, 99.5% support
Tidewater Inc.2026-06-16Election of Directors - To elect seven (7) directors each for a one-year term: Melissa CougleAbstainFOR — 5 of 6 Brighthouse fundsAgainstElected, 99.8% support
Tidewater Inc.2026-06-16Election of Directors - To elect seven (7) directors each for a one-year term: Quintin V. KneenAbstainFOR — 5 of 6 Brighthouse fundsAgainstElected, 99.5% support
Tidewater Inc.2026-06-16Election of Directors - To elect seven (7) directors each for a one-year term: Robert E. RobottiAbstainFOR — 5 of 6 Brighthouse fundsAgainstElected, 97.7% support
Tidewater Inc.2026-06-16Say on Pay Vote - An advisory vote to approve executive compensation as disclosed in the proxy statement.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 99.1% support
Avista Corporation2026-05-14Advisory (non-binding) vote on executive compensation.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 96.5% support
Avista Corporation2026-05-14Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 96.8% support
M/I Homes, Inc.2026-05-13A non-binding, advisory resolution to approve the compensation of the named executive officers of M/I Homes, Inc.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 95.7% support
M/I Homes, Inc.2026-05-13To ratify the appointment of Deloitte & Touche LLP as M/I Homes, Inc.'s independent registered public accounting firm for the 2026 fiscal year.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 98.2% support
Tarsus Pharmaceuticals, Inc.2026-06-25To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Scott MorrisonWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.4% support
Tarsus Pharmaceuticals, Inc.2026-06-25To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Wendy YarnoWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.9% support
Tarsus Pharmaceuticals, Inc.2026-06-25To hold an advisory vote to approve, on a non-binding basis, our named executive officer compensation.AbstainFOR — 3 of 3 Brighthouse fundsAgainst—
Tarsus Pharmaceuticals, Inc.2026-06-25To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 100.0% support
Rigetti Computing, Inc.2026-06-09To ratify the appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 99.2% support
Primoris Services Corporation2026-04-30To elect eight Directors to hold office for a one-year term expiring at the Annual Meeting of Stockholders to be held in 2027 or until a successor is qualified and elected: Carla S. MashinskiWithholdFOR — 5 of 6 Brighthouse fundsAgainst—
Primoris Services Corporation2026-04-30To elect eight Directors to hold office for a one-year term expiring at the Annual Meeting of Stockholders to be held in 2027 or until a successor is qualified and elected: David L. KingWithholdFOR — 5 of 6 Brighthouse fundsAgainst—
Primoris Services Corporation2026-04-30To elect eight Directors to hold office for a one-year term expiring at the Annual Meeting of Stockholders to be held in 2027 or until a successor is qualified and elected: Harpreet SalujaWithholdFOR — 5 of 6 Brighthouse fundsAgainst—
Primoris Services Corporation2026-04-30To elect eight Directors to hold office for a one-year term expiring at the Annual Meeting of Stockholders to be held in 2027 or until a successor is qualified and elected: Jose R. RodriguezWithholdFOR — 5 of 6 Brighthouse fundsAgainst—
Primoris Services Corporation2026-04-30To elect eight Directors to hold office for a one-year term expiring at the Annual Meeting of Stockholders to be held in 2027 or until a successor is qualified and elected: Koti VadlamudiWithholdFOR — 5 of 6 Brighthouse fundsAgainst—
Primoris Services Corporation2026-04-30To elect eight Directors to hold office for a one-year term expiring at the Annual Meeting of Stockholders to be held in 2027 or until a successor is qualified and elected: Michael E. ChingWithholdFOR — 5 of 6 Brighthouse fundsAgainst—
Primoris Services Corporation2026-04-30To elect eight Directors to hold office for a one-year term expiring at the Annual Meeting of Stockholders to be held in 2027 or until a successor is qualified and elected: Patricia K. WagnerWithholdFOR — 5 of 6 Brighthouse fundsAgainst—
Primoris Services Corporation2026-04-30To elect eight Directors to hold office for a one-year term expiring at the Annual Meeting of Stockholders to be held in 2027 or until a successor is qualified and elected: Terry D. McCallisterWithholdFOR — 5 of 6 Brighthouse fundsAgainst—
Primoris Services Corporation2026-04-30To ratify the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; andAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 99.2% support
OSI Systems, Inc.2025-12-11Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2026.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 100.0% support
Central Garden & Pet Company2026-02-11To approve an advisory vote on the compensation of the Company's named executive officers as described in the accompanying proxy statement.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 98.7% support
Central Garden & Pet Company2026-02-11To ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending on September 26, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 98.7% support
Resideo Technologies, Inc.2026-06-03Advisory Vote to Approve Executive Compensation.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 96.8% support
Resideo Technologies, Inc.2026-06-03Ratification of the Appointment of Independent Registered Public Accounting Firm.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 99.8% support
Constellium SE2026-05-21Allocation of the results of the Company for the fiscal year ended December 31, 2025AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 100.0% support
Constellium SE2026-05-21Approval of the aggregate maximum amount of the directors' annual fixed feesAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 100.0% support
Constellium SE2026-05-21Approval of the consolidated financial statements and transactions for the fiscal year ended December 31, 2025AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 100.0% support
Constellium SE2026-05-21Approval of the statutory financial statements and transactions for the fiscal year ended December 31, 2025AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 100.0% support
Constellium SE2026-05-21Approval, on an advisory (non-binding) basis, of the 2025 compensation of the Company's named executive officersAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 93.2% support
Constellium SE2026-05-21Discharge (quitus) of the directors, the Chief Executive Officer, and the Statutory Auditors of the Company in respect of the performance of their duties for the fiscal year ended December 31, 2025AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 86.7% support
Constellium SE2026-05-21Powers to carry out formalitiesAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 100.0% support
Constellium SE2026-05-21Ratification of the interim appointment of Ms. Ingrid Joerg as a directorAbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 99.7% support
IMAX Corporation2026-06-10Appointment of Auditors Appointment of PricewaterhouseCoopers LLP as Auditors of the Company for the ensuing year and authorizing the Directors to fix their remuneration.WithholdFOR — 3 of 3 Brighthouse fundsAgainstApproved, 98.9% support
IMAX Corporation2026-06-1010 wordings Election of Directors Election of the ten nominees for the Board of Directors: Gail BermanAgainstFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 92.5% support
Xencor, Inc.2026-06-16Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers, as disclosed in this Proxy Statement.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 96.6% support
Pediatrix Medical Group, Inc.2026-05-07Approve the Pediatrix Medical Group, Inc. Second Amended and Restated 2008 Incentive Compensation PlanAbstainFOR — 3 of 3 Brighthouse fundsAgainst—
Immunome, Inc.2026-06-09To approve, on an advisory basis, the compensation of our named executive officers.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 98.4% support
Immunome, Inc.2026-06-09To ratify the appointment of Ernst & Young LLP our independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 100.0% support
Ducommun Incorporated2026-04-29Advisory resolution to approve executive compensation.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 94.3% support
Ducommun Incorporated2026-04-29Approval of Amendment and Restatement of the Company's 2024 Stock Incentive Plan.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 96.7% support
Ducommun Incorporated2026-04-29Ratification of the selection of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 95.0% support
Dorian LPG Ltd.2025-09-05Approval, on an advisory, non-binding basis, of the compensation of our named executive officers, as disclosed in this proxy statement.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 87.5% support
Dorian LPG Ltd.2025-09-05Election of Directors: John C. HadjipaterasWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.2% support
Dorian LPG Ltd.2025-09-05Election of Directors: Malcolm McAvityWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 93.0% support
Dorian LPG Ltd.2025-09-05Election of Directors: Mark RossWithholdFOR — 3 of 3 Brighthouse fundsAgainstElected, 99.4% support
Dorian LPG Ltd.2025-09-05Ratification of the appointment of Deloitte Certified Public Accountants S.A. as the Company's independent auditors for the fiscal year ending March 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 98.9% support
BioCryst Pharmaceuticals, Inc.2026-06-11To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 96.7% support
GeneDx Holdings Corp.2026-06-18Approval, on a non-binding advisory basis, the compensation of our named executive officers.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 93.9% support
GeneDx Holdings Corp.2026-06-18Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.4% support
NuScale Power Corporation2025-12-16A proposal to adjourn the Special Meeting, if necessary or appropriate, to solicit additional proxies if a quorum is not present or there are insufficient votes at the time of the Special Meeting to approve the Authorized Share Increase Amendment.AbstainFOR — 3 of 3 Brighthouse fundsAgainst—
Healthcare Services Group, Inc.2026-05-26To approve an amendment to the Company's 2020 Amended Omnibus Incentive Plan to increase the number of shares of our common stock authorized for issuance by 2,500,000 shares.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 95.6% support
Healthcare Services Group, Inc.2026-05-26To approve and ratify Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 98.1% support
Healthcare Services Group, Inc.2026-05-26To consider an advisory vote on a non-binding resolution to approve the compensation of our named executive officers.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 97.9% support
Enovis Corporation2026-05-19Election of Directors: A. Clayton PerfallAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.4% support
Enovis Corporation2026-05-19Election of Directors: Angela S. LalorAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 99.0% support
Enovis Corporation2026-05-19Election of Directors: Barbara W. BodemAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 99.6% support
Enovis Corporation2026-05-19Election of Directors: Brady ShirleyAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.5% support
Enovis Corporation2026-05-19Election of Directors: Christine OrtizAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 99.6% support
Enovis Corporation2026-05-19Election of Directors: Damien McDonaldAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.9% support
Enovis Corporation2026-05-19Election of Directors: Liam J. KellyAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 99.6% support
Enovis Corporation2026-05-19Election of Directors: Philip A. OkalaAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 99.6% support
Enovis Corporation2026-05-19Election of Directors: Rajiv VinnakotaAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.9% support
Enovis Corporation2026-05-19Election of Directors: Sharon WienbarAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 99.6% support
Enovis Corporation2026-05-19To approve an amendment to the Enovis Corporation 2020 Omnibus Incentive Plan.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 97.5% support
Enovis Corporation2026-05-19To approve on an advisory basis the compensation of our named executive officers.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 95.8% support
Enovis Corporation2026-05-19To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 98.3% support
A10 Networks, Inc.2026-04-22To ratify the appointment of Grant Thornton LLP as our independent public accounting firm for our fiscal year ending December 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.9% support
NovoCure Limited2026-06-03A non-binding advisory vote to approve executive compensation.AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 91.0% support
NovoCure Limited2026-06-03Election of Directors: Allyson OceanAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.0% support
NovoCure Limited2026-06-03Election of Directors: Asaf DanzigerAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.3% support
NovoCure Limited2026-06-03Election of Directors: David HungAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 97.5% support
NovoCure Limited2026-06-03Election of Directors: Frank LeonardAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 99.6% support
NovoCure Limited2026-06-03Election of Directors: Jeryl HillemanAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.4% support
NovoCure Limited2026-06-03Election of Directors: Kinyip Gabriel LeungAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 95.9% support
NovoCure Limited2026-06-03Election of Directors: Kristin StaffordAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.5% support
NovoCure Limited2026-06-03Election of Directors: Martin MaddenAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.2% support
NovoCure Limited2026-06-03Election of Directors: Timothy ScannellAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.4% support
NovoCure Limited2026-06-03Election of Directors: William DoyleAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 96.8% support
NovoCure Limited2026-06-03Election of Directors: William VernonAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.2% support
NovoCure Limited2026-06-03The approval and ratification of the appointment, by the Audit Committee of our Board of Directors, of Kost Forer Gabbay & Kasierer, a member of Ernst & Young Global, as the auditor and independent registered public accounting firm of the Company for the Company's fiscal year ending December 31, 202AbstainFOR — 3 of 3 Brighthouse fundsAgainstApproved, 97.5% support
Proto Labs, Inc.2026-05-19Advisory vote on executive compensation.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 82.3% support
Proto Labs, Inc.2026-05-19Approval of the amendment to the Amended and Restated Proto Labs, Inc. 2022 Long-Term Incentive Plan.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 97.6% support
Proto Labs, Inc.2026-05-19Ratification of the selection of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 97.9% support
Stewart Information Services Corporation2026-05-07Approval of the compensation of Stewart Information Services Corporation's named executive officers (Say-on-Pay).AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 98.5% support
Stewart Information Services Corporation2026-05-07Ratification of the appointment of KPMG LLP as Stewart Information Services Corporation's independent auditors for 2026.AbstainFOR — 5 of 6 Brighthouse fundsAgainstApproved, 99.1% support
Turning Point Brands, Inc.2026-05-04Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.2% support
Turning Point Brands, Inc.2026-05-04To approve, on an advisory basis, named executive officer compensation.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 97.8% support
Adient plc2026-03-10Election of Directors: Barb J. SamardzichAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.1% support
Adient plc2026-03-10Election of Directors: Frederick A. HendersonAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.9% support
Adient plc2026-03-10Election of Directors: Jerome J. DorlackAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 99.7% support
Adient plc2026-03-10Election of Directors: Jodi E. EddyAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 99.2% support
Adient plc2026-03-10Election of Directors: Julie L. BushmanAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.2% support
Adient plc2026-03-10Election of Directors: Peter H. CarlinAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.2% support
Adient plc2026-03-10Election of Directors: Richard GoodmanAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.2% support
Universal Insurance Holdings, Inc.2026-06-11Election of twelve directors: Carol G. BartonAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.5% support
Universal Insurance Holdings, Inc.2026-06-11Election of twelve directors: Francis X. McCahill, IIIAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.6% support
Universal Insurance Holdings, Inc.2026-06-11Election of twelve directors: Jon W. SpringerAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.4% support
Universal Insurance Holdings, Inc.2026-06-11Election of twelve directors: Kimberly D. CamposAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 97.7% support
Universal Insurance Holdings, Inc.2026-06-11Election of twelve directors: Marlene M. GordonAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.4% support
Universal Insurance Holdings, Inc.2026-06-11Election of twelve directors: Michael A. PietrangeloAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 97.7% support
Universal Insurance Holdings, Inc.2026-06-11Election of twelve directors: Ozzie A. SchindlerAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 97.9% support
Universal Insurance Holdings, Inc.2026-06-11Election of twelve directors: Richard D. PetersonAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 97.5% support
Universal Insurance Holdings, Inc.2026-06-11Election of twelve directors: Scott P. CallahanAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 90.7% support
Universal Insurance Holdings, Inc.2026-06-11Election of twelve directors: Sean P. DownesAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 97.1% support
Universal Insurance Holdings, Inc.2026-06-11Election of twelve directors: Shannon A. BrownAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.8% support
Universal Insurance Holdings, Inc.2026-06-11Election of twelve directors: Stephen J. DonaghyAbstainFOR — 3 of 3 Brighthouse fundsAgainstElected, 98.5% support
Community Trust Bancorp, Inc.2026-04-28Proposal to approve the advisory (nonbinding) resolution relating to executive compensation.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 97.2% support
Community Trust Bancorp, Inc.2026-04-28Proposal to ratify and approve the appointment of BDO USA, P.C. as Community Trust Bancorp, Inc.'s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.9% support
Vistance Networks, Inc.2026-05-07Approval of additional shares under the Company's 2019 Long-Term Incentive Plan.AbstainFOR — 5 of 6 Brighthouse fundsAgainstPassed (calculated), 97.7% support
Old Second Bancorp, Inc.2026-05-19Proposal to approve on a non-binding, advisory basis, the compensation of the Company's named executive officers, as described in the Company's Proxy Statement.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 98.1% support
Old Second Bancorp, Inc.2026-05-19Proposal to ratify the appointment of Plante & Moran, PLLC as the Company's independent registered public accountants for the fiscal year ending December 31, 2026.AbstainFOR — 3 of 3 Brighthouse fundsAgainstPassed (calculated), 99.4% support

959 more in the CSV.

Download all 1,459 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 95.8% of this fund’s 4,517 such votes could be given a sector; the other 188 (4.2%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care99500.0%
Consumer Discretionary90300.0%
Technology66600.0%
Industrials62120.3%
Finance58800.0%
Basic Materials10300.0%
Utilities9600.0%
Energy9100.0%
Real Estate8500.0%
Miscellaneous8000.0%
Telecommunications6900.0%
Consumer Staples3200.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections3,0270
Say-on-Pay5622
Audit-related5310
Compensation1860
Corporate Governance1020
Capital Structure490
Extraordinary Transactions420
Shareholder Rights and Defenses370
Environment or Climate20
Human Rights or Human Capital/workforce20

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
agilon health, inc.March 17, 2026$4M20
Bloom Energy CorporationMay 21, 2026$3M80
Lumentum Holdings Inc.November 19, 2025$2M110
Nextracker Inc.August 18, 2025$2M50
Guardant Health, Inc.June 17, 2026$1M50
Glaukos CorporationMay 28, 2026$1M40
Moderna, Inc.November 12, 2025$1M20
Ensign Group, Inc.May 13, 2026$1M60

Notable votes against management

MeetingCompanyProposalFundMgmt
May 21, 2026Constellium SEAdvisory (non-binding) vote to hold an advisory (non-binding vote) on the compensation of the Company's named executive officers every two yearsAgainstFor
May 21, 2026Constellium SEAdvisory (non-binding) vote to hold an advisory (non-binding vote) on the compensation of the Company's named executive officers every three yearsAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (3 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

4,543 ballot items at 579 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, AVIP BlackRock Advantage Small Cap Growth Portfolio voted at 579 shareholder meetings of 560 companies, on 4,543 ballot items in all. Where management made a recommendation, the fund followed it on 41.4% of the items and voted against it 2 times. Its most frequent area of disagreement was say-on-pay (2 of its votes against management). It voted on 25 shareholder proposals. It voted FOR the board's own proposals less often than Brighthouse's funds as a whole (2.1% against 76.3%). It voted differently from most Brighthouse funds on 1,459 items. 3 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Brighthouse’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.